Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Flumazenil

A benzodiazepine receptor antagonist, first described in 1981 and on the market since 1987: it is used to reverse benzodiazepine sedation, for example after anaesthesia. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?The first benzodiazepine antagonist is itself a benzodiazepine, more precisely an imidazobenzodiazepine: it occupies the same site on the GABA-A receptor but without activating it.

FlumazenilGo to the active ingredient →
FlumazenilActive ingredientFlumazenilCat. No. P-F077-001CAS 78755-81-4
Flumazenil-d5Isotopically labelledFlumazenil-d5Cat. No. P-F077-009CAS 2700278-14-2

EDQM standards 1

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.